We investigated whether transforming growth factor (TGF)-b1 promoted epithelialmesenchymal transition (EMT) and migration of human oral squamous cell carcinoma (hOSCC) cells. Among 6 hOSCC cell lines investigated, Smad2 phosphorylation and TGF-b target genes expression were most clearly upregulated following TGF-b1 stimulation in HSC-4 cells, indicating that HSC-4 cells were the most responsive to TGF-b1. In addition, the expression levels of the mesenchymal markers N-cadherin and vimentin were most clearly induced in HSC-4 cells among the hOSCC cell lines by TGF-b1 stimulation. Interestingly, E-cadherin and b-catenin at the cell surface were internalized in HSC-4 cells stimulated with TGF-b1. In addition, the expression levels of the EMT-related transcription factor Slug was significantly upregulated on TGF-b1 stimulation. Moreover, the downregulation of Slug by RNA interference clearly inhibited the TGF-b1-induced expression of mesenchymal marker and the migration of HSC-4 cells. Proteomics analysis also revealed that the expression levels of integrin a3b1-targeted proteins were upregulated in TGF-b1-stimulated HSC-4 cells. Neutral antibodies against integrin a3 and b1, as well as a focal adhesion kinase (FAK) inhibitor, clearly suppressed TGF-b1-induced cell migration. These results suggest that the EMT and integrin a3b1/FAK pathwaymediated migration of TGF-b1-stimulated HSC-4 hOSCC cells is positively controlled by Slug.
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It is well known that transforming growth factor (TGF)-b inhibits the growth of epithelial cells (1, 2) . In addition, TGF-b generally induces the secretion of extracellular matrix (ECM) proteins from epithelial cells (3) . TGF-b exerts multiple effects by binding to transmembrane serine/threonine kinases, TGF-b receptor type I (TbR-I) and TGF-b receptor type II (TbR-II). TbR-I is phosphorylated and activated by TbR-II kinase upon ligand-induced heteromeric complex formation between TbR-I and TbR-II and mediates specific intracellular signal pathways through the phosphorylation of receptor-regulated Smads (R-Smads). Phosphorylated R-Smads associate with Smad4 and translocate to the nucleus where they control the transcription of target genes in cooperation with other transcription factors and transcriptional co-activators or co-repressors (4, 5) . In cancer, TGF-b is associated with malignant transformation and the aggravation of cancer through the induction of the epithelialmesenchymal transition (EMT) (reviewed in 6, 7). TGF-b signalling pathway plays critical and dual roles in the progression of human cancer. TGF-b acts as a tumour suppressor at the early stage of tumour progression. In contrast, TGF-b also promotes tumour progression, for example tumour cell invasion, dissemination and immune evasion (8) . Therefore, the functional outcome of the TGF-b-induced response is strongly dependent on the type of cancer cells (3) .
EMT is a process that allows a polarized epithelial cell to assume a mesenchymal cell phenotype, which is characterized by enhanced motility and invasiveness (9) . In addition, EMT also causes the disruption of cellcell adherence, loss of apicobasal polarity, matrix remodelling and increased motility and invasiveness, thereby promotes tumour metastasis (8, 10) . The tumour microenvironment plays an important role in facilitating cancer metastasis and may induce EMT in tumour cells: the large number of inflammatory cells infiltrating the tumour site, hypoxia existing in a large area of the tumour and the many stem cells present in the tumour microenvironment, such as cancer and mesenchymal stem cells, may induce EMT in tumour cells (10) . EMT is characterized by the loss of epithelial markers such as E-cadherin, the downregulation of cytokeratins, the upregulation of mesenchymal markers such as N-cadherin and vimentin and the acquisition of a fibroblast-like motile and invasive phenotype (11) . In addition, disruption of E-cadherin-mediated adherens junctions causes the translocation of b-catenin from the cell membrane into the cytoplasm. Then, b-catenin enters the nucleus and transactivates genes via the canonical Wnt signalling pathway (1214). Thus, Wnt/b-catenin activation is an integral part of EMT (15, 16) . Nuclear localization of b-catenin is predominant in human oral squamous cell carcinoma (hOSCC) cells at the invasive front (17) . On the other hand, various signalling pathways are involved in EMT, including TGF-b, NF-kB, Notch and others (10, 18) . It is known that many transcriptional factors participate in EMT (19, 20) , for example Snail (21), Slug (22) , Twist (23) and FOXC2 (24) . Recently, it was reported that several EMT-promoting transcriptional factors such as Snail, zinc finger E-boxbinding homeobox (ZEB) 1 and ZEB2 act as cofactors of Smads (25) . The interaction between Smads and EMT-promoting transcriptional factors results in the formation of EMT-promoting Smad complexes that engage in both repressing epithelial genes and activating mesenchymal genes.
Conversely, several ECM proteins are expressed during TGF-b-induced EMT (19) . Thrombospondine-1 (TSP-1) is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions (26, 27) . The plasminogen activation system is negatively regulated by plasminogen activator inhibitor-1 (PAI-1; also known as SERPINE1), which inhibits the activity of urokinase-type plasminogen activator (uPA) by binding to it (28) . TGF-b-inducible gene-h3 (big-h3; also known as TGFBI) is an ECM protein identified as a major TGF-b-responsive gene (29) . Fibronectin is also recognized as a TGF-b-inducible ECM protein during EMT (30) . Recent advanced studies in tumour biology revealed that complex interactions of tumour cells with their adjacent microenvironment involving the ECM are necessary for the expression of various mechanisms involved in tumour development and progression (reviewed in 31). Thus, the interaction between tumour cells and the ECM seems to control most aspects of tumorigenesis, such as EMT, along with the subsequent tumour cell migration.
Various hOSCC cell lines have been used as models to study aspects of tumorigenesis such as EMT or migration of oral cancer in vitro, whereas only a few studies have examined how TGF-b affects the EMT of hOSCC cells (3234). In particular, the molecular mechanisms underlying the TGF-b-induced EMT or EMT-associated hOSCC cell migration remain to be clarified. Here, we evaluated Smad2 phosphorylation and the expression levels of TGF-b target genes such as Smad7, fibronectin and PAI-1 following TGF-b1 stimulation in various hOSCC cells to identify TGF-b1-responsive hOSCC cells. Then, to examine whether TGF-b1 responsiveness is closely related to the EMT of hOSCC cells, we evaluated the expression of epithelial and mesenchymal cell markers in hOSCC cells, as well as EMT-associated cell migration, after TGF-b1 stimulation. In addition, we investigated the type of transcriptional factors that cause TGFb1-induced EMT. We also investigated the molecular mechanisms underlying EMT-associated cell migration. This is the first report to demonstrate the molecular mechanisms underlying TGF-b1-induced EMT and the EMT-associated migration of hOSCC cells.
Materials and Methods

Materials
Cultured cell lines were obtained from the Human Science Resource Cell Bank (Osaka, Japan). Recombinant human TGF-b1 was purchased from PEPROTECH (Rocky Hill, NJ, USA). The TbRI kinase inhibitor SB431542 and focal adhesion kinase (FAK) inhibitor I (1,2,4,5-benzenetetramine, 4HCl) were provided by MerckMillipore (Frankfurt, Germany). Protease inhibitor cocktail for use with mammalian cell and tissue extracts and phosphatase inhibitor cocktail 1 and 2 were purchased from Sigma-Aldrich (St. Louis, MO, USA). All of the other reagents were of analytical grade.
Cell culture
All human squamous cell carcinoma cell lines were grown at 37 C and 5% CO 2 . HSC-2 and HSC-4 cells were cultured in Eagle's minimum essential medium (MEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Gibco BRL, Rockville, MD, USA). SAS cells were cultured in RPMI1640 medium (Gibco BRL) supplemented with 10% FBS. HO-1-N1 and OSC-19 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) and Ham's F-12 medium (1:1; Gibco BRL) with 10% FBS. HSC-3 cells were cultured in DMEM (Gibco BRL) containing 10% FBS. The culture medium was removed and replaced with serum-free medium 24 h before the TGF-b1-stimulated experiments. In the experiments pertaining to the production of ECM proteins, 1.0 Â 10 4 hOSCC cells were cultured in 200 mL medium without serum containing 10 ng/mL TGF-b1 for 48 or 120 h in 96-well tissue culture plates. The conditioned media were harvested and then concentrated by ultrafiltration with Microcon-10 filters (cutoff, 10 kDa; Merck). The obtained media were treated with an equal volume of sample buffer (Laemmli 2Â concentrate; Sigma-Aldrich). The samples were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDSPAGE).
Western blot analysis
For the experiments on Smad phosphorylation, 3.0 Â 10 6 cells were lysed in radio-immunoprecipitation assay (RIPA) buffer (50 mM TrisHCl [pH 7.2], 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS) containing a protease and phosphatase inhibitor cocktail (Sigma-Aldrich). The protein content of the samples was measured using the bicinchoninic acid (BCA) reagent (Pierce, Rockford, IL, USA). For the preparation of cell lysates to examine marker proteins, 1.0 Â 10 6 cells were cultured in a six-well plate in serum-free MEM with or without 10 ng/mL TGF-b1 for the indicated times. The cells were dissolved in SDS sample buffer containing a protease and phosphatase inhibitor cocktail (SigmaAldrich). Acrylamide gels of 7.5 or 12.5% (ATTO Co., Tokyo, Japan) for SDSPAGE were used for protein separation, and the proteins were subsequently transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). The membranes were probed with the primary antibodies anti-Smad2/3 mouse antibody (BD Transduction Laboratories, Franklin Lakes, NJ, USA) and anti-phospho-Smad2 (Ser465/467) (Cell Signaling, Beverly, MA, USA), while an anti-b-actin antibody (clone C4; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used as a loading control in the Smad phosphorylation experiments (Fig. 1A) . Anti-fibronectin (P1H11; Santa Cruz), anti-PAI-1 (H-135; Santa Cruz), anti-big-h3 (R&D Systems, Minneapolis, MN, USA) and anti-TSP-1 (N-20; Santa Cruz) antibodies were used for the detection of extracellular proteins (Figs 1C and 6B). Anti-E-cadherin (clone 36; BD Transduction Laboratories), anti-vimentin (sc-6260; Santa Cruz), anti-cytokeratin18 (sc-6259; Santa Cruz) and anti-Ncadherin (8C11; Santa Cruz) antibodies were used for the detection of marker proteins (Fig. 3A) . Anti-Slug (A-7; Santa Cruz) and anti-lamin B (C-20; Santa Cruz) antibodies were also used for western blot analysis (Fig. 4C) . The blots were incubated with alkaline phosphataseconjugated secondary antibody, and signals were detected using an alkaline phosphatase substrate kit (BCIP/NBT Substrate Kit; Vector Laboratories Inc., Burlingame, CA, USA). For the evaluation of Smad2 phosphorylation, the proteins were detected using the appropriate horseradish peroxidaseconjugated secondary antibodies and an Amersham ECL TM Prime Western Blotting Detection Reagent (GE Healthcare, Buckinghamshire, UK).
Quantitative real-time RTPCR
For total RNA preparation, 1.0 Â 10 6 cells were cultured in 6-cm dishes. Total RNA was isolated using the ISOGEN reagent (Nippon Gene, Toyama, Japan) according to the manufacturer's instructions. We reverse transcribed 4 mg total RNA to first-strand cDNA using the poly-A primer provided in the RTPCR System Kit (Takara Bio Inc., Shiga, Japan). Quantitative real-time reverse transcriptase polymerase chain reaction (qRTPCR) was performed on a Thermal Cycler Dice Real Time System (Takara Bio) using SYBR Premix Ex Taq II (Takara Bio) with gene-specific primers (listed in Table I ). The mRNA expression levels of the target genes were normalized to that of the endogenous reference gene b-actin and were shown in terms of fold increase or decrease relative to the level of the control sample.
Suppression of gene expression by small interfering RNAs
The sense sequence of human Slug small interfering RNA (siRNA; MISSION siRNA, Sigma-Aldrich) is 5 0 -GCAUUUGCAGACAGG UCAATT-3 0 . Logarithmically growing cells were seeded at a density of 1Â 10 5 cells per 6-cm dish and transfected with 10 nM siRNA using Lipofectamine RNAiMAX (Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. Fortyeight hours after transfection, cells were stimulated using 10 ng/mL TGF-b1 and then used for qRTPCR analysis of vimentin gene expression or the wound healing assay as described below. Stealth TM RNAi Negative Control High GC Duplex (Life Technologies), which does not possess significant homology to vertebrate gene sequences, was used as a negative control. Suppression of gene expression by siRNA was evaluated by qRTPCR and western blotting analyses for the targeted molecules.
Confocal microscopy
Cells plated on eight-well chamber slides were incubated at 37 C for 24 h and then stimulated with 10 ng/mL TGF-b1 for a further 48 h. Some cells were treated with 10 mM SB431542 at 30 min before TGF-b1 treatment. The slides were fixed with 4% paraformaldehyde at room temperature for 15 min. Epithelial and mesenchymal marker proteins (Fig. 3B) were detected using the following method. The cells were treated with the following specific antibodies (1:200): anti-E-cadherin (clone 36), anti-cytokeratin18 (sc-6259), anti-N-cadherin (clone 32; BD Transduction Laboratories), anti-vimentin (sc-6260), anti-b-catenin (#9587; Cell Signaling) and anti-a-smooth muscle actin (a-SMA; Abcam Ltd, Cambridge, UK) for 90 min. After the cells were rinsed with phosphate-buffered saline (PBS), they were stained with Alexa Fluor Õ 488 goat anti-mouse or anti-rabbit antibodies (1:1000; Life Technologies) for 1 h at room temperature and then with 4 0 -6-diamidino-2-phenylindole (DAPI; 1:500, Sigma-Aldrich) for 10 min. The slides were washed and observed using confocal microscopy (C1 si, Nikon, Tokyo, Japan). Cytoskeletal proteins (Fig. 5C ) were observed using the following method. After rinsing, cells were stained with Alexa Fluor Õ 488-conjugated phalloidin (Life Technologies, Grand Island, NY, USA) and an anti-vinculin antibody (clone hVIN-1; SigmaAldrich) for 1 h at room temperature and then with DAPI (1:500; Sigma-Aldrich) for 10 min. Then, the slides were washed with PBS and observed as described above.
Wound healing assay
The cells were seeded at a density of 5.0 Â 10 5 cells into each well of six-well plates. First, the cells were transfected with Slug siRNA as described above. Then, the cells were treated with 10 ng/mL TGF-b1 under serum-free conditions with or without reagents such as SB431542, anti-integrin b1 antibody (clone 6S6; Merck), anti-integrin a3 antibody (clone P1B5; Merck) or FAK inhibitor I. These reagents were added to the culture 30 min before TGF-b1 stimulation. Then, the cells were incubated in a serum-free medium for 48 h before wounding. Scratch wounds of 20 mm in length were made by a scratch with the plane head of a 10-mL white micropipette tip. The pictures of the wounds were taken at 0 min and 12 h after wounding. The cells were observed using a 10 Â objective on an Olympus photomicroscope (Olympus Corporation, Tokyo, Japan) equipped with a fluorescence detector. 
All photographs are representatives of three independent experiments.
Cell migration assay with a Boyden chamber Boyden chamber migration assays were performed as follows. First, the cells were transfected with Slug siRNA as described above. Then, the cells were treated with 10 ng/mL TGF-b1 under serum-free conditions with or without reagents such as SB431542, anti-integrin b1 antibody (clone 6S6) or anti-integrin a3 antibody (clone P1B5) for 72 h. Subsequently, the cells were plated at a density of 1.0 Â 10 5 cells in the upper chamber of a Boyden chamber apparatus in serum-free media with or without SB431542 or the neutralizing antibodies described above and were allowed to migrate into medium containing 10% FBS in the lower chamber for 24 h at 37 C. Following the 24 h incubation, the filter was fixed in 4% paraformaldehyde and stained with hematoxylineosin (Sigma-Aldrich) for 16 h. Cells that had migrated onto the underside of the membrane were counted in nine fields on the membrane. The values are average of triplicate experiments. The migration of the control was set to 100%, and all other datasets were measured against this value. The level of significance was determined using the Student's t-test.
Mass spectrometry analysis SDSPAGE was carried out on a gel that contained a 1020% acrylamide gradient gel (ATTO Co., Tokyo, Japan). Protein bands were stained with Flamingo fluorescent gel stain (BIO-RAD, Hercules, CA, USA). The bands were cut out from the gel and washed three times with a 100 mM ammonium carbonate/acetonitrile (1:1 v/v) solution with shaking. Protein thiol groups in the gels were reduced and then alkylated by iodoacetamide. Digestion of proteins in the gel pieces was carried out using 10 mg/mL trypsin (Promega, Madison, WI, USA) for 1216 h at 37 C. The liquid was collected, and the resulting peptides were recovered after two extractions with a solution containing 50% acetonitrile/2.5% formic acid. The digestion mixture was subjected to a reversed-phase column (Zorbax 300 S-C18, 3.5 mm, 150 Â 0.3 mm; Agilent, Santa Clara, CA, USA) by capillary high-performance liquid chromatography (Agilent 1100 System; Agilent). The peptides were eluted with a gradient of 1065% acetonitrile in 0.1% formic acid. Ion-trap tandem mass spectrometry was carried out on an HCT ultra si (Bruker Daltonics, Bremen, Germany), according to the manufacturer's instructions. Protein sequence database searches were performed with Mascot (Matrix Science, Boston, MA, USA) using the MS/MS peptide ions.
Statistical analysis
All experiments were performed at least three times independently. The results are expressed as the mean AE standard deviation (SD). Data were analyzed using the unpaired Student's t-test. In all The production of extracellular matrix proteins from hOSCC cell lines stimulated with TGF-b1 was examined using western blotting. We cultured 1.0 Â 10 4 cells in 200 mL medium without serum containing 10 ng/mL TGF-b1 for 48 or 120 h in a 96-well dish. The conditioned media were harvested, and 12.5 mL of each sample was treated with SDS sample buffer and electrophoresed on 7.5% SDS-polyacrylamide gels followed by western blotting with anti-fibronectin (FN) and anti-PAI-1 antibodies. statistical analyses, a P50.05 was considered statistically significant, and all P values are two-sided. (Fig. 1B) . The protein expression of fibronectin was highly upregulated in HSC-4 cells after TGF-b1 stimulation and moderately upregulated in HO-1-N-1 and SAS cells (Fig. 1C) . In addition, the protein expression of PAI-1 was clearly upregulated in HSC-4 and SAS cells (Fig. 1C) and moderately upregulated in HO-1-N-1 cells. These results suggest that among the hOSCC cell lines tested, HO-1-N-1, HSC-4 and SAS cells are TGF-b1-responsive, whereas HSC-2, HSC-3 and OSC-19 cells are poorly responsive to TGF-b1. Moreover, among three types of TGF-b1-responsive hOSCC cells, HSC-4 cells were the most responsive to TGF-b1 stimulation (Fig. 1AC) . In addition, the upregulation of TGF-b target gene expression levels by TGF-b1 stimulation in HSC-4 cells were suppressed by SB431542 (data not shown). Fig. 2 Effects of TGF-b1 on the expression levels of EMT-related markers in TGF-b-stimulated hOSCC cell lines. The mRNA expression levels of EMT-related markers in hOSCC cell lines after treatment with TGF-b1 in serum-free medium were analyzed using qRTPCR. The primers for qRTPCR are described in Table I . The cells were stimulated with (gray bars) or without (black bars) 10 ng/mL TGF-b1 for 48 h. The expression levels of (A) E-cadherin (left) and anti-cytokeratin18 (right) as epithelial markers and (B) N-cadherin (left) and vimentin (right) as mesenchymal markers were examined. The values have been normalized to the b-actin mRNA levels. Data are the mean AE SD of quadruplicate experiments (*P50.05; **P50.01).
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Effects of TGF-b1 on the expression of EMT-related markers in TGF-b-stimulated hOSCC cells To obtain insights into the relationship between TGF-b1-responsiveness and TGF-b1-induced EMT progression in hOSCC cells, we investigated the effects of TGF-b1 on the expression of EMT-associated genes in TGF-b1-responsive (HSC-4, HO-1-N-1 and SAS) and poorly responsive (HSC-2, HSC-3 and OSC-19) hOSCC cells. qRTPCR analyses revealed that the downregulation of definitive epithelial cell markers E-cadherin and cytokeratin18 was not observed in all the hOSCC cells ( Fig. 2A) . In contrast, the definitive mesenchymal marker N-cadherin was strongly upregulated in both HSC-4 and SAS cells and moderately in HSC-2 cells (Fig. 2B, left panel) . In addition, the definitive mesenchymal marker vimentin was strongly upregulated in HSC-4 cells and moderately in HO-1-N-1 cells (Fig. 2B, right panel) . Thus, among TGF-b1-responsive cell lines, mesenchymal markers were most strongly upregulated after TGF-b1 stimulation in HSC-4 cells (Fig. 2B) . In addition, the upregulation of mesenchymal markers in TGF-b1-stimulated HSC-4 cells was suppressed by SB431542 (data not shown).
Expression and localization of EMT-related marker proteins in TGF-b1-treated HSC-4 cells
We examined the protein levels of EMT markers in HSC-4 cells stimulated with TGF-b1. Western blotting analysis revealed that the expression levels of N-cadherin and vimentin were significantly increased in HSC-4 cells at 48 h after TGF-b1 treatment and weakly at 120 h (Fig. 3A) . However, the expression levels of E-cadherin and cytokeratin18 were hardly affected by TGF-b (Fig. 3A) . Interestingly, immunofluorescence analysis revealed that E-cadherin and b-catenin at the cell surface were internalized in HSC-4 cells stimulated with TGF-b1 (Fig. 3B) . Immunofluorescence analysis also clearly revealed that the mesenchymal markers a-SMA, N-cadherin and vimentin were expressed in HSC-4 cells with TGF-b treatment, but not in cells that did not receive TGF-b treatment (Fig. 3B) .
Regulation of TGF-b1-induced EMT of HSC-4 cells by Slug
Various transcription factors are related to EMT in different cell types (1923); therefore, we investigated the mRNA expression levels of EMT-related transcription factors in HSC-4 cells using qRTPCR. Slug expression level was significantly upregulated at 24 h after TGF-b1 stimulation (Fig. 4A ). In addition, the TGF-b1-induced upregulation of Slug expression was suppressed by SB431542 (data not shown). However, no change was observed in the expression levels of Twist1/2, ZEB1/ZEB2 and FOXC2 at 6 h, or ZEB1 at 48 h, after TGF-b1 stimulation (data not shown). These data suggest that Slug is important EMT-related transcription factor in HSC-4 cells stimulated with TGF-b1. To investigate how these transcriptional factors affect the EMT of HSC-4 cells, HSC-4 cells treated with Slug siRNA were stimulated with TGF-b1. The expression of Slug was lower in HSC-4 cells treated with Slug siRNA than in those treated with control siRNA at both the mRNA and protein levels ( Fig. 4B  and C) . qRTPCR analysis revealed that Slug siRNA significantly suppressed the TGF-b1-induced expression of vimentin mRNA in HSC-4 cells compared with that of control siRNA (Fig. 4D) . In contrast, Slug siRNA did not affect the expression of N-cadherin mRNA in HSC-4 cells (Supplementary Fig. S1 ).
Regulation of EMT-related cell migration of HSC-4 cells by Slug
Migration ability, which is related to tumour invasion and metastasis, following TGF-b1 stimulation of HSC-4 cells was examined using a wound healing assay. The cell migration ability of HSC-4 cells was increased following TGF-b1 stimulation but was inhibited by SB431542 or Slug siRNA in the wound healing assay (Fig. 5A ). This inhibition of the cell migration ability of TGF-b1-stimulated HSC-4 cells by SB431542 and Slug siRNA was also observed in the migration chamber assay (Fig. 5B) . In general, cell adhesion plays essential roles in cell movement: The generation of focal adhesion sites is necessary for the stable adhesion of the lamellipodium or filopodium in migrating cells (reviewed in 38). At focal adhesion sites, vinculin is involved in mechanocoupling between integrins bound to the underlying ECM and the actin cytoskeleton (3941). In TGF-b1-stimulated HSC-4 cells, many focal adhesion contacts were detected as The localization of EMT-related marker proteins was observed using confocal microscopy. The cells were cultured with or without 10 ng/mL TGF-b1 under serum-free conditions for 48 h. These cells were immunostained with the indicated antibodies, stained with DAPI to detect nuclei, and observed using confocal microscopy, as described in Materials and Methods. The scale bars represent 25 mm.
punctate spots of vinculin around the lamellipodiumlike structure ( Fig. 5C, arrowheads ; red punctate). Interestingly, some spots of vinculin were seen to colocalize with actin stress fibers, which were prevalent around at the lamellipodium-like structure ( Fig. 5C , arrows; yellow).
Identification of ECM proteins secreted from TGF-b1-treated HSC-4 cells
Our next aim was to elucidate the molecular mechanisms underlying the TGF-b-induced migration of HSC-4 cells, by identifying extracellular protein molecules secreted by HSC-4 cells that played a role in TGF-b-induced cell migration. We identified extracellular proteins from TGF-b1-treated HSC-4 cells using SDSPAGE (Fig. 6A) . Some of the detected protein bands were enriched at 120 h of TGF-b1 stimulation, in comparison with unstimulated HSC-4 cells. These proteins were digested with trypsin, and the peptide fragments were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mass data were analyzed using Mascot software against a protein database to identify the proteins (Table II) . The expression levels of fibronectin, PAI-1, big-h3 and TSP-1 were upregulated after TGF-b1 stimulation. These results were confirmed by western blotting using anti-fibronectin, anti-PAI-1 (Fig. 1C) , anti-big-h3 and anti-TSP-1 antibodies (Fig. 6B) .
Roles of integrin and FAK on cell migration of TGF-b1-treated HSC-4 cells
The TGF-b1-induced extracellular proteins, TSP-1, big-h3, fibronectin and uPA receptor (uPAR), a related molecule to PAI-1, are integrin a3b1-targeted molecules (4245). Therefore, we examined how integrin a3b1 on the surface of HSC-4 cells affected TGF-b-induced cell migration. The effects of blocking 
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antibodies against integrin a3 and b1 on the TGF-b-stimulated migratory activity of HSC-4 cells were examined using the wound healing assay (Fig. 7A ) and the migration chamber assay (Fig. 7B) . TGF-b-stimulated migratory activity was clearly suppressed by blocking antibodies against integrins a3 and b1 (Fig. 7A and B) . We also investigated the expression of integrins a3 and b1 in TGF-b-stimulated HSC-4 cells by qRTPCR (Fig. 7C and D) . The expression levels of both integrin a3 and b1 increased significantly at 72 or 96 h after TGF-b1 stimulation. In contrast, integrin expression was not upregulated within 48 h. As FAK is an important regulator of cell migration and signal transduction from integrins, we evaluated the effect of FAK inhibitor I on the TGF-b-induced migration of HSC-4 cells. The TGF-b1-induced migration activity of HSC-4 cells was inhibited by 10 ng/mL FAK inhibitor I in the wound healing assay (Fig. 7E) .
Discussion
TGF-b1 clearly induced Smad2 phosphorylation in HSC-4 and SAS cells (Fig. 1A) . The expression levels of the TGF-b target genes Smad7, fibronectin and PAI-1 were clearly upregulated in HSC-4, HO-1-N-1 and SAS cells after TGF-b1 stimulation (Fig. 1B and  C) . These results suggest that HO-1-N-1, HSC-4 and SAS cells were TGF-b1-responsive hOSCC cells.
Conversely, the definitive mesenchymal marker N-cadherin was clearly upregulated in HSC-4 and SAS cells after TGF-b1 treatment (Fig. 2B, left) . In addition, the definitive mesenchymal marker vimentin was clearly upregulated in HSC-4 and HO-1-N-1 cells after TGF-b1 treatment (Fig. 2B, right) . These results suggest that responsiveness to TGF-b1 is closely and positively related to the induction of the mesenchymal phenotype in hOSCC cells. Moreover, HSC-4 cells seemed to be the most typical TGF-b-responsive hOSCC cells with mesenchymal phenotype expression (Figs 1, 2B and 3) . Interestingly, E-cadherin and b-catenin at the cell surface were internalized in HSC-4 cells stimulated with TGF-b1 (Fig. 3B) , whereas the expression level of E-cadherin was hardly affected (Fig. 3A) . The internalization of E-cadherin during EMT progression has been reported previously (46, 47) . expression and the increased expression of EMTrelated transcription factors such as Snail and Slug in hOSCC cells (34, 49) . However, the mechanism by which EMT-related transcription factors affect the EMT marker expression in hOSCC cells remained to be clarified. Here, we have demonstrated that the expression of Slug was increased in response to TGF-b1 (Fig. 4A) . To investigate whether Slug affected the expression levels of the TGF-b1-induced mesenchymal markers N-cadherin and vimentin, Slug siRNA was added to the HSC-4 cell culture before TGF-b1 stimulation. Slug downregulation significantly suppressed TGF-b1-induced vimentin expression in HSC-4 cells (Fig. 4BD ) but did not affect TGF-b1-induced N-cadherin expression (Supplementary Fig. S1 ). These data suggested that Slug contributes to the expression of mesenchymal marker genes during the EMT of HSC-4 cells. Conversely, the Snail mRNA expression transiently increased after the TGF-b1 stimulation (data not shown). The function of Snail in TGF-b1-stimulated HSC-4 cells is now under investigation in our laboratory.
It has been widely recognized that cell migration is an EMT-related event (50, 51) , which is related to tumour invasion and metastasis. It has been reported that the EMT-related transcription factor Slug enhances the migration activity of corneal epithelial cells (52) . However, the effect of Slug on the EMT-related migration of hOSCC cells remained to be clarified. In this study, wound healing and migration chamber assays demonstrated that Slug downregulation by Slug siRNA clearly suppressed the TGF-b1-induced migration ability of HSC-4 cells (Fig. 5A and B) . In general, cell adhesion plays essential roles in cell movement: The generation of focal adhesion sites is necessary for stable adhesion of the lamellipodium or filopodium in migrating cells (reviewed in 38). In TGF-b1-stimulated HSC-4 cells, many focal adhesion contacts were detected as punctate spots of vinculin, and actin stress fibers were observed around the lamellipodium-like structure (Fig. 5C) . Thus, punctate vinculin seemed to play a positive role in the TGF-b1-induced migration of HSC-4 cells.
Next, we attempted to identify secreted extracellular proteins generated by TGF-b1 treatment by directly analyzing the proteins in the culture medium using LC-MS/MS. We found that the expression levels of fibronectin, PAI-1, big-h3, and TSP-1 were enriched after TGF-b1 stimulation (Fig. 6A) . These results were confirmed by western blotting using antifibronectin, anti-PAI-1 (Fig. 1C) , anti-big-h3 and anti-TSP-1 antibodies (Fig. 6B) . The N-terminal domain of TSP-1 binds to integrin a3b1 on the surface of endothelial cells to induce their proliferation and angiogenesis (42) . PAI-1-related molecule uPAR forms a complex with integrin a3b1 and induces epithelial cell migration (45) . big-h3 has multiple cell adhesion motifs that can mediate interactions with a variety of cell types via integrin a3b1 (43) . Integrin a3b1 on human melanoma cells binds to fibronectin, thereby increasing the invasive capacity of the cells (53) . Therefore, we expected that the increased expression of fibronectin, PAI-1, TSP-1 and big-h3 affected the migration ability of HSC-4 cells following TGF-b1 stimulation through integrin a3b1. TGF-b1 Induces EMT in HSC-4
( Fig. 7A and B) . Thus, TGF-b1-induced migration activity in HSC-4 cells was dependent on integrin a3b1. Interestingly, integrin a3 and b1 expression levels were upregulated in HSC-4 cells at 72 and 96 h after TGF-b stimulation ( Fig. 7C and D) , suggesting that the TGF-b-induced expression of integrin a3b1 might play positive roles in cell migration. Conversely, some of the TGF-b1-induced extracellular proteins might also play positive roles in cell migration. We investigated whether fibronectin played a positive role in HSC-4 cell migration after TGF-b1 stimulation. However, a blocking antibody against fibronectin or the fibronectin-related peptide GRGDSP, which blocks fibronectin, did not affect the migration of Before wounding, the cells were cultured with or without 10 ng/mL TGF-b1 for 48 h in the presence of control IgG, integrin a3 -or b1-blocking antibodies (10 mg/mL). Control IgG means 10 mg/mL mouse IgG from normal mouse serum, which was used instead of a blocking antibody as a control. The appearance of cells migration was observed by phase-contrast microscopy at indicated times after the wounding. (B) The migration ability of the cells cultured with or without 10 ng/mL TGF-b1 in the presence of control IgG, integrin a3-and b1-blocking antibodies (10 mg/mL) was assayed using a Boyden chamber as described in the Materials and Methods. Data are the mean AE SD of experiments in three dishes for each time point (*P50.05; **P50.01) (C and D). The time course of integrin a3 and b1 mRNA expression in the cells after treatment with 10 ng/mL TGF-b1 was analyzed using qRTPCR. The primers for qRTPCR are described in Table I . The expression levels of (C) integrin a3 and (D) integrin b1 were examined at the indicated time points. The values have been normalized to the b-actin mRNA levels. Data are the mean AE SD of triplicate experiments (*P50.05; **P50.01). (E) The effect of a FAK inhibitor on the TGF-b1-induced cell migration was examined using a wound healing assay. Before wounding, the cells were cultured with or without 10 ng/mL TGF-b1 for 48 h. Some cells were pretreated with 10 mM FAK inhibitor I at 30 min before the TGF-b1 stimulation. After wounding, the cells were incubated for indicated times and the appearance of cells migration was observed using phase-contrast microscopy.
TGF-b1-stimulated HSC-4 cells (data not shown). These results suggest that ECM components other than fibronectin contribute to migration. FAK is an important regulator of cell migration, which is required for the invasion and metastasis of cancer cells (54, 55) . In general, FAK is activated by integrins and functions as a positive regulator of cell migration (55) : Activated FAK associates with regulatory proteins that promote the activation of Rho family proteins, which promote cell migration (56) . As shown in Fig. 7E , the TGF-b-induced migration of HSC-4 cells was inhibited by FAK inhibitor I. These results suggest that TGF-b-induced migration activity was transduced by the integrin a3b1/FAK signal pathway.
In summary, we have demonstrated that the TGF-b1-induced EMT and EMT-related migration of HSC-4 hOSCC cells are positively controlled by Slug and the integrin a3b1/FAK pathway. This is the first report investigating the molecular mechanisms underlying TGF-b1-induced EMT and EMT-related migration in hOSCC cells.
Supplementary Data
Supplementary data are available at JB Online.
